http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2155535-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
filingDate 1995-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2001-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d1c06ae170025af34b07100a93039dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f74c38d31c347507ef0add5eb5db8bf5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_622e2b26049c4235b63c4a1dfdee08b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd353bc9b009350567061c9d0ce4b4a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f0794995559a2efe556150433665b1f
publicationDate 2001-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2155535-T3
titleOfInvention APOLIPROTEIN B SYNTHESIS INHIBITORS B.
abstract THE PRESENT INVENTION PROVIDES NEW COMPOUNDS OF FORMULA (I), N-OXIDES, STEREOCHEMICALLY ISOMERIC FORMS, AND ACID, PHARMACEUTICALLY ACCEPTABLE, ADDITIONAL SALTS OF THE SAME. IN FORMULA (I), AYB, UNITED, FORM A BIVALENT RADICAL OF FORMULA: -N = CH- (A), -CH = N- (B), CH {SUB, 2} -CH {SUB, 2} - (C), CH = CH- (D), -C (= O) -CH {SUB, 2} - (E), -CH {SUB, 2} -C (= O) - (F); R {SUP, 1} IS HYDROGEN, RENT C {SUB, 1-6}, OR HALO; R {SUP, 2} IS HYDROGEN OR HALO; R {SUP, 3} IS HYDROGEN; C {SUB, 1-8}, C {SUB, 3-6} CYCLE-RENT OR C {SUB, 1-8} RENT REPLACED WITH HYDROXY, OXO, C {SUB, 3-6} CYCAL-RENT OR ARYL. HET IS A FIVE OR SIX MEMBER, OPTIONALLY REPLACED RING. IT IS ALSO DESCRIBED ITS USE AS A MEDICINE, ESPECIALLY AS A LIPID REDUCING AGENT, AS WELL AS PHARMACEUTICAL COMPOSITIONS AND PROCEDURES FOR THE PREPARATION OF SUCH COMPOUNDS AND COMPOSITIONS.
priorityDate 1994-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457655803

Total number of triples: 30.